Survival and prognostic factors in hepatitis B virus-related acute-on-chronic liver failure

doi:10.3748/wjg.v17.i29.3448

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 29

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4627)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

452

HTML

3704

Figures (1-2)

233

Tables (1-3)

238

Sum=4627

Aug 7, 2011 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (48)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 7, 2011; 17(29): 3448-3452
Published online Aug 7, 2011. doi: 10.3748/wjg.v17.i29.3448

Open in New Tab Full Size Figure Download Figure

Figure 1 Survival curves for patients taking or not taking antiviral drugs by Kaplan-Meier method. Total, n = 190; antiviral drugs, n = 141; no antiviral drugs, n = 49.

Open in New Tab Full Size Figure Download Figure

Figure 2 Survival curves for the entecavir and lamivudine groups by Kaplain-Meier method. Total, n = 141; entecavir group, n = 77; lamivudine group, n = 64.

Citation: Huang K, Hu JH, Wang HF, He WP, Chen J, Duan XZ, Zhang AM, Liu XY. Survival and prognostic factors in hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol 2011; 17(29): 3448-3452
URL: https://www.wjgnet.com/1007-9327/full/v17/i29/3448.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i29.3448